Drug Database · Clinicians

Adjuvanted + Adsorbed + Human papillomavirus vaccine types 16 + Recombinant

Brands (1) CervarixShow all

Vaccine PH FDA category
Fixed-dose combination.

Rx · Prescription drug2 PH products
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
US label not yet available for this generic. Check the Philippine package insert (linked in the products table where the FDA has published one).

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Registered products in the Philippines

2 products registered with the Food and Drug Administration (FDA) Philippines list Adjuvanted + Adsorbed + Human papillomavirus vaccine types 16 + Recombinant as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

Philippine FDA-registered products for Adjuvanted + Adsorbed + Human papillomavirus vaccine types 16 + Recombinant
Package insert
CervarixHuman Papillomavirus Vaccine [Types 16 and 18] (Recombinant, adjuvanted, adsorbed)
Formulation: 1 dose (0.5 mL) contains: Human Papillomavirus type 16 L1 protein*. Human Papillomavirus type 18 L1 protein*. .20 mcg ...... 20 mcg *adjuvanted by AS04 containing 3-O-desacyl-4'-monophosphoryl lipid A (MPL) and Aluminum hydroxide, hydrated [Al(OH)3] Suspension for Injection (IM)1 mL in 3 mL Type I Glass Vial with Vaccine Vial Monitor (Box of 1's and 100's)
Rx
GlaxoSmithKline Biologicals SABelgium
GlaxoSmithKline Philippines, Inc.
BR-925
Mar 23, 2027
CervarixHuman Papillomavirus Vaccine [Types 16 and 18] (Recombinant, adjuvanted, adsorbed)
Formulation: 1 dose (0.5 mL) contains: Human Papillomavirus type 16 Ll protein*..............20 mcg Human Papillomavirus type 18 L1 protein*... ...........20 mcg *adjuvanted by AS04 containing 3-O-desacyl-4-monophosphoryl lipid A (MPL) and Aluminum hydroxide, hydrated [Al(OH)3] Suspension for Injection (IM)0.5 mL in 3 mL Type I glass vial (Box of 10's and 100's)
Rx
GlaxoSmithKline Biologicals SABelgium
GlaxoSmithKline Philippines, Inc.
BR-783
Mar 23, 2027

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .